APA

Klaassen D. J., Boyes D. A., Gerulath A., Levitt M., Miller A. B. & Pearson J. G. (19790901). Preliminary report of a clinical trial of the treatment of patients with advanced stage III and IV ovarian cancer with melphalan, 5-fluorouracil, and methotrexate in combination and sequentially: a study of the Clinical Trials Group of the National Cancer Institute of Canada. : Cancer treatment reports.

Chicago

Klaassen D J, Boyes D A, Gerulath A, Levitt M, Miller A B and Pearson J G. 19790901. Preliminary report of a clinical trial of the treatment of patients with advanced stage III and IV ovarian cancer with melphalan, 5-fluorouracil, and methotrexate in combination and sequentially: a study of the Clinical Trials Group of the National Cancer Institute of Canada. : Cancer treatment reports.

Harvard

Klaassen D. J., Boyes D. A., Gerulath A., Levitt M., Miller A. B. and Pearson J. G. (19790901). Preliminary report of a clinical trial of the treatment of patients with advanced stage III and IV ovarian cancer with melphalan, 5-fluorouracil, and methotrexate in combination and sequentially: a study of the Clinical Trials Group of the National Cancer Institute of Canada. : Cancer treatment reports.

MLA

Klaassen D J, Boyes D A, Gerulath A, Levitt M, Miller A B and Pearson J G. Preliminary report of a clinical trial of the treatment of patients with advanced stage III and IV ovarian cancer with melphalan, 5-fluorouracil, and methotrexate in combination and sequentially: a study of the Clinical Trials Group of the National Cancer Institute of Canada. : Cancer treatment reports. 19790901.